AzTrials
AzTrials

Postpartum Weight RetentionNCT05579990

Feasibility of Meal Delivery Postpartum

A study testing Meal Delivery in people with Postpartum Weight Retention and Obesity, run by University of Alabama at Birmingham at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This study is being done to assess the feasibility and acceptability of a meal delivery intervention among low-income postpartum women with obesity. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Postpartum Weight Retention, Obesity
What is being tested?
Meal Delivery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
27 Sep 2023to 11 Sep 2025
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Medicaid eligible and/or have a household income at or below 185 percent of the federal poverty line
  • 18 years of age or older
  • Initiated prenatal care at a University of Alabama at Birmingham prenatal clinic
  • Experienced a healthy singleton pregnancy
  • 5-45 weeks postpartum at enrollment
  • Body mass index >= 30 at enrollment
  • Residing within the meal company's delivery radius
  • Willing to consent

Who cannot join

  • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
  • Current treatment for severe psychiatric disorder (such as schizophrenia)
  • Self-reported diagnosis of anorexia or bulimia
  • Current use of medication expected to significantly impact body weight
  • Current substance abuse
  • Participation in another dietary and/or weight management intervention postpartum
  • Unable to understand and communicate in English
  • Unwilling or unable to consume study meals

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294

Other trials in United States

About this study

Official title: Feasibility of a Meal Delivery Intervention for Postpartum Weight Management

This study is being done to assess the feasibility and acceptability of a meal delivery intervention among low-income postpartum women with obesity.

Read the detailed description

This is a single-group pilot study in which subjects will receive 10 home-delivered meals per week for 8 weeks.

Being tested
Meal Delivery
Keywords
Postpartum, Weight management, Meal delivery
Medical subject headings
Gestational Weight Gain, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meal DeliveryBehavioural

    10 home-delivered meals per week provided by a local meal delivery company supplemented by remote weekly behavioral support with study staff.

Study groups in NCT05579990
Study groupRoleWhat they receive
Meal DeliveryExperimentalMeal delivery intervention program designed to help low income postpartum women lose weight through weekly meal delivery and behavioral strategies.
Receives: Behavioral: Meal Delivery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Reported Proportion of Received Study Meals Consumed

    Proportion of received weekly study meals participants reported consuming each week collected via weekly electronic surveys in which participants will self-report the number of study meals a) they consumed, b) other household members consumed, or c) that were uneaten.

    Measured: Collected weekly from intervention start (6-45 weeks postpartum) to follow-up (14-53 weeks postpartum)

Secondary outcomes (3)
  1. Study Participation Rate

    Total number of eligible subjects who agreed to participate out of those who were screened.

    Measured: baseline (5-45 weeks postpartum)

  2. Participant Retention

    The number of enrolled participants who completed some or all follow-up assessment visit measurements.

    Measured: baseline (5-45 weeks postpartum), follow-up (14-53 weeks postpartum)

  3. Change in Participant Satisfaction With Diet

    To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire (DSAT-28) will be used in which participants respond to 28 statements using a 5-point Likert scale. Responses to all 28-items are averaged to produce a total diet satisfaction score (designed to reflect satisfaction as it relates to following a weight-management diet) ranging from 1-5. Subscale scores for Cost Factor (reflects financial cost of the diet) and Planning \& Preparation Factor (reflects amount of time and effort spent in planning and preparing) will also be calculated and range from 1-5. For the overall diet satisfaction score and subscale scores, higher scores represent greater satisfaction. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning \& Preparation Factor will be examined from baseline to follow-up.

    Measured: baseline (5-45 weeks postpartum), follow-up (14-53 weeks postpartum)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2022
  2. Study start27 Sep 2023
  3. Primary completion29 Jul 2024
  4. Study completion11 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05579990
Sponsor's protocol ID
IRB-300010155
Other IDs
U54MD000502
Status last verified
Sep 2025
First submitted
11 Oct 2022
Last updated
23 Sep 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) that underlie the results reported in a publication will be made available upon request beginning 9 months and ending 36 months following article publication. The research team will keep a record of all individuals and/or research teams who request and receive a copy of the project data. Interested investigators will be asked to submit a document indicating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications). The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in